Hence, unsurprisingly, the dysregulation of USP2 levels was associated with the development of various kinds of cancers, such as colorectal cancer [44], prostate cancer [43] and oral squamous cell carcinoma [46]. This evidence concerns the gene USP2 and prostate carcinoma.